CHOSA — Chosa Oncology AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK60.75m
- SEK58.96m
- SEK0.00m
Annual balance sheet for Chosa Oncology AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | PRESS | PRESS |
| Standards: | SAS | — | SAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 29.6 | 15.1 | 8.77 | 6.44 | 1.79 |
| Net Total Receivables | 10.3 | 10.5 | 0.753 | 1.23 | 1.69 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 55.8 | 30.1 | 9.53 | 7.74 | 3.63 |
| Net Intangible Assets | |||||
| Total Assets | 55.8 | 30.1 | 19.4 | 21.4 | 20.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14.1 | 20.7 | 2.02 | 2.77 | 3.71 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.1 | 20.7 | 2.02 | 2.77 | 3.71 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 41.7 | 9.39 | 17.4 | 18.6 | 16.5 |
| Total Liabilities & Shareholders' Equity | 55.8 | 30.1 | 19.4 | 21.4 | 20.3 |
| Total Common Shares Outstanding |